Libre Duo - GoKawiil

Abbott wins FDA clearance for Libre Duo, a combined glucose-ketone monitor

Abbott has received FDA authorization for the Libre Duo, its first continuous glucose monitor that tracks both blood glucose and ketone levels in a single wearable sensor. The device requires a prescription and lasts 10 days, mirroring the design of Abbott's existing Libre CGM lineup but adding ketone detection aimed at catching dangerous spikes before they turn into ketoacidosis.

theverge.com · 2026-09-02

FDA clears Libre Duo 10 Day, first device tracking ketones and glucose together

The FDA has authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for diabetes patients aged 2 and up. It is the first wearable in the U.S. to continuously track ketone levels and the first worldwide to combine continuous ketone and glucose monitoring in one device. Sensors measure both substances every minute in fluid beneath the skin and send readings wirelessly to a paired smartphone.

fda.gov · 2026-08-25